Short-Chain Fatty Acids Alleviate Hepatocyte Apoptosis Induced by Gut-Derived Protein-Bound Uremic Toxins

Abstract

Chronic kidney disease (CKD) is characterized with the influx of uremic toxins, which impairs the gut microbiome by decreasing beneficial bacteria that produce short-chain fatty acids (SCFAs) and increasing harmful bacteria that produce gut-derived protein-bound uremic toxins (PBUTs). This study aimed to assess the proapoptotic effects of three major gut-derived PBUTs in hepatocytes, and the effects of SCFAs on apoptosis phenotype in vitro. HepG2 (human liver carcinoma cells) and THLE-2 (immortalized human normal liver cells) cell line were incubated with 0, 2, 20, 200, 2000 μM p-cresol sulfate (PCS), indoxyl sulfate (IS), and hippuric acid (HA), respectively, for 24 h. Flow cytometry analysis indicated that three uremic toxins induced varying degrees of apoptosis in hepatocytes and HA represented the highest efficacy. These phenotypes were further confirmed by western blot of apoptosis protein expression [Caspase-3, Caspase-9, B-cell lymphoma 2 (Bcl-2), and Bcl-2-associated X protein (Bax)]. Human normal hepatocytes (THLE-2) are more sensitive to PBUTs-induced apoptosis compared with human hepatoma cells (HepG2). Mechanistically, extracellular HA could enter hepatocytes, increase reactive oxygen species (ROS) generation, and decrease mitochondrial membrane potential dose-dependently in THLE-2 cells. Notably, coculture with SCFAs (acetate, propionate, butyrate) for 24 h significantly improved HA-induced apoptosis in THLE-2 cells, and propionate (500 μM) represented the highest efficacy. Propionate reduction of apoptosis was associated with improving mitochondria dysfunction and oxidative stress in a manner involving reducing Caspase-3 expression, ROS production, and increasing the Bcl-2/Bax level. As such, our studies validated PBUTs accumulation might be an important cause of liver dysfunction in patients with CKD, and supplementation of SCFAs might be a viable way to protect the liver for patients with CKD.

Salidroside Ameliorates Furan-Induced Testicular Inflammation in Relation to the Gut-Testis Axis and Intestinal Apoptosis

“…Similarly, phytosphingosine was found to induce carcinoma cell apoptosis . Furthermore, we concentrated on an interesting metabolite, hippuric acid, which is a common intestinal metabolite that can induce apoptosis . These further confirmed the implication of ERS-mediated apoptosis in the mechanism.…”

“…46 Furthermore, we concentrated on an interesting metabolite, hippuric acid, which is a common intestinal metabolite that can induce apoptosis. 47 These further confirmed the implication of ERS-mediated apoptosis in the mechanism. What is more, it is exciting that a testosteronerelated substance named methyltestosterone was found.…”

Association between gut microbiota and hepatocellular carcinoma from 2011 to 2022: Bibliometric analysis and global trends

“…Short-chain fatty acids (SCFAs) are generated in the colon by the fermentation of dietary fiber by gut microbiota. Hepatocytes can utilize SCFAs as a source of energy, which can lower glucose production by the liver and enhance insulin sensitivity ( 39 , 40 ). SCFAs can also stimulate the secretion of intestinal hormones, including glucagon-like peptide-1 (GLP-1), which can further enhance insulin secretion and improve glucose metabolism ( 41 ).…”

Yishen Qingli Heluo Granule Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats by Targeting Gut Microbiota and Intestinal Barrier Integrity

“…Evidence showed that the concentrations of SCFAs, especially acetic acid and butyric acid, were significantly reduced in CKD. However, improved intestinal barrier and renal function were observed through the supplementation of SCFAs, especially butyric acid ( Deng et al, 2021 ). Previous studies indicated that the alleviation of renal dysfunction was related to the improved SCFA concentrations and intestinal barrier.…”